Disclosed positions

Estimated from their latest filings — positions may have changed since

$199.51M

combined est. value

Stock	Shares	Price	Value	Weight	As of
DVADAVITA INC.	840,408	$237.36	$199.48M	100%	2026-06-16
BTAIBioXcel Therapeutics, Inc.	26,838	$1.19	$31.9K	0%	2026-06-15

DVA

DAVITA INC.

$199.48M

840,408 sh

BTAI

BioXcel Therapeutics, Inc.

$31.9K

26,838 sh

All filings on record

Every Form 4 transaction we track for this filer

all 14buys 0sells 3

Stock	Transaction	Date	~6mo later
DVADAVITA INC.	Sell $8.25M · 39,407 sh	2026-06-16	—
BTAIBioXcel Therapeutics, Inc.	Exercise — · 35 sh	2026-06-15	—
DVADAVITA INC.	Sell $6.29M · 30,000 sh	2026-06-15	—
BTAIBioXcel Therapeutics, Inc.	Sell $7.1K · 6,560 sh	2026-05-20	—
BTAIBioXcel Therapeutics, Inc.	Exercise — · 17,500 sh	2026-05-04	—
BTAIBioXcel Therapeutics, Inc.	Exercise — · 35 sh	2025-12-15	—
BTAIBioXcel Therapeutics, Inc.	Exercise — · 33 sh	2025-12-14	—
DVADAVITA INC.	Tax $627.8K · 5,165 sh	2025-11-15	—
BTAIBioXcel Therapeutics, Inc.	Exercise — · 35 sh	2025-09-15	—
BTAIBioXcel Therapeutics, Inc.	Exercise — · 33 sh	2025-09-14	—
BTAIBioXcel Therapeutics, Inc.	Exercise — · 625 sh	2025-07-22	—
BTAIBioXcel Therapeutics, Inc.	Grant — · 4,375 sh	2025-07-22	—
BTAIBioXcel Therapeutics, Inc.	Exercise — · 35 sh	2025-06-15	—
BTAIBioXcel Therapeutics, Inc.	Exercise — · 33 sh	2025-06-14	—

DVASell

2026-06-16 · DAVITA INC.

$8.25M

—

BTAIExercise

2026-06-15 · BioXcel Therapeutics, Inc.

35

—

DVASell

2026-06-15 · DAVITA INC.

$6.29M

—

BTAISell

2026-05-20 · BioXcel Therapeutics, Inc.

$7.1K

—

BTAIExercise

2026-05-04 · BioXcel Therapeutics, Inc.

17,500

—

BTAIExercise

2025-12-15 · BioXcel Therapeutics, Inc.

35

—

BTAIExercise

2025-12-14 · BioXcel Therapeutics, Inc.

33

—

DVATax

2025-11-15 · DAVITA INC.

$627.8K

—

BTAIExercise

2025-09-15 · BioXcel Therapeutics, Inc.

35

—

BTAIExercise

2025-09-14 · BioXcel Therapeutics, Inc.

33

—

BTAIExercise

2025-07-22 · BioXcel Therapeutics, Inc.

625

—

BTAIGrant

2025-07-22 · BioXcel Therapeutics, Inc.

4,375

—

BTAIExercise

2025-06-15 · BioXcel Therapeutics, Inc.

35

—

BTAIExercise

2025-06-14 · BioXcel Therapeutics, Inc.

33

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.